Microcurrent Treatment for Chronic Debilitating Pain

Microcurrent Treatment for Chronic Debilitating Pain

To compare the efficacy of standard pain treatment and placebo (a microcurrent faux treatment) as opposed to standard pain treatment and microcurrent therapy in any primary care patients over a three month period.

This study is not intended to be definitive and should be considered an exploratory randomized trial to determine conditions for which microcurrent is more effective. Thus, extensive subgroup analyses will be performed so that definitive trials can be developed. This is a single-blind study where subjects will not know if they are receiving microcurrent treatment.

**Patients must be able to get care at Nellis Air Force Base (a military installation) in order to participate in this study**

Inclusion Criteria:

• Male and female Active Duty members and DoD beneficiaries
• Age 18 years or older
• Chronic debilitating pain
• PROMIS-57 T score is 60 or above

Exclusion Criteria:

• Pregnant
• Implanted pacemaker
• Spinal cord stimulator
• Illicit drug use including marijuana use
• Epilepsy or a history of seizures
• Other implanted device (e.g., insulin pump, opioid pump, or defibrillator)
• Chronic debilitating pain referred or recruited as measured by PROMIS-57 T score is below 60